Stock data
| Market cap. | £10.6m |
| Last close | 12.38p |
| High / Low (52 weeks) | 16.2p / 9.8p |
| Stock market listing | AIM |
| Forecast net debt (£m) | 0.1 |
| Forecast gearing ratio (%) | 1 |
| Team | Healthcare |
| Sector | Pharmaceutical & Healthcare |
Price performance
| % | 1m | 3m | 12m |
|---|---|---|---|
| Actual | 1.02 | 15.12 | (8.33) |
| Relative * | 5.98 | 24.57 | 0.74 |
* % Relative to local index
Other companies covered in sector
| Y/E Mar | Revenue (£m) | EBITDA (£m) | PBT (£m) | EPS (p) | P/E (x) | P/CF (x) |
|---|---|---|---|---|---|---|
| 2010A | 6.2 | 0.7 | 0.6 | 2.9 | 4.3 | 11.3 |
| 2011A | 7.9 | 0.9 | 0.7 | 1.7 | 7.3 | 6.2 |
| 2012E | 11.1 | 1.2 | 0.9 | 0.9 | 13.8 | 19.0 |
| 2013E | 13.0 | 1.6 | 1.3 | 1.3 | 9.5 | 7.4 |
Last updated on 04/05/2012
Latest research
Passage to India
Update | Pharmaceutical & Healthcare | 03/05/2012
Allergy iSYS progress
Review | Pharmaceutical & Healthcare | 02/03/2012
Vorsprung durch Allergie
Outlook | Pharmaceutical & Healthcare | 08/07/2011
Allergic abundance
Update | Pharmaceutical & Healthcare | 03/12/2010
Final results statement
Update | Pharmaceutical & Healthcare | 23/07/2010
Smart testing on track
Update | Pharmaceutical & Healthcare | 26/04/2010
Smart testing
Outlook | Pharmaceutical & Healthcare | 17/12/2009
Investment summary
FY12 had revenue of £11.12m, up 5% on a like for like basis. We project an FY12 adjusted PBT of £906k. Development of the 40-50 core test menu for iSYS allergy is underway for a spring 2013 launch. The new Indian sales subsidiary starts trading on 1 August 2012 and could add up to £448k of additional revenue in FY13 to make £848k. The extra revenues include Indian Food Detective sales after its relaunch.
Last updated on 03/05/2012
Industry outlook
Omega’s allergy division tests for IgE, the clinical basis of allergy, rather than IgG, as in food intolerance tests. The allergy test market is worth c $600m. Progress in moving the 40-50 launch test menu to the iSYS is steady. However, two of the eight proof-of-concept tests are not yet ready for validation. Edison now expects a launch in mid-March 2013 at the earliest.
Last updated on 23/04/2012
Key management
| Andrew Shepherd, CEO |
| Kieron Harbinson, FD |
Company address
| One London Wall London EC2Y 5AB United Kingdom +44 (0) 1259 763 030 View website |
